Come up with a name for your new list and we'll add to it:
Caelus Health raised a round of funding on February 02, 2017. Investors include
Johnson & Johnson.
Caelus Health is an Amsterdam-based biotech company developing an entirely new class of Microbiome Therapeutics for the reduction of insulin resistance and prevention of Type 2 Diabetes (T2DM) in peop…